{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:45:02Z","timestamp":1792449902327,"version":"4.5.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":114,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13311-023-01376-2","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:11:34Z","timestamp":1682075494000},"page":"1037-1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["The Promise of Niacin in Neurology"],"prefix":"10.1016","volume":"20","author":[{"given":"Emily","family":"Wuerch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Roldan","family":"Urgoiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-3563","authenticated-orcid":false,"given":"V. Wee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01376-2_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/nu10070846","article-title":"Dietary intake and food sources of niacin, riboflavin, thiamin and vitamin B6 in a representative sample of the Spanish population. The anthropometry, intake, and energy balance in Spain (ANIBES) study \u2020","volume":"10","author":"Mielgo-Ayuso","year":"2018","journal-title":"Nutrients"},{"key":"10.1007\/s13311-023-01376-2_bib2","first-page":"125","article-title":"Pathophysiology and clinical management of pellagra - a review","volume":"61","author":"Ho\u0142ubiec","year":"2021","journal-title":"Folia Med Crac"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/phpp.12659","article-title":"Pellagra a review exploring causes and mechanisms, including isoniazid-induced pellagra","volume":"37","author":"Prabhu","year":"2021","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1007\/s13311-023-01376-2_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1074248413514481","article-title":"The therapeutic role of niacin in dyslipidemia management","volume":"19","author":"Boden","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1007\/s13311-023-01376-2_bib5","unstructured":"Organization WH. Pellagra and its prevention and control in major emergencies. 2000."},{"issue":"9","key":"10.1007\/s13311-023-01376-2_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-9149(00)00703-7","article-title":"Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia","volume":"85","author":"Goldberg","year":"2000","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2020-324286","article-title":"Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis","volume":"92","author":"Cunniffe","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00401-020-02129-7","article-title":"Niacin-mediated rejuvenation of macrophage\/microglia enhances remyelination of the aging central nervous system","volume":"139","author":"Rawji","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-023-01376-2_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11010-019-03670-0","article-title":"Potential therapeutic effects of antagonizing adenosine A(2A) receptor, curcumin and niacin in rotenone-induced Parkinson\u2019s disease mice model","volume":"465","author":"Motawi","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"637","key":"10.1007\/s13311-023-01376-2_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl7634","article-title":"The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease","volume":"14","author":"Moutinho","year":"2022","journal-title":"Sci Transl Med"},{"issue":"537","key":"10.1007\/s13311-023-01376-2_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9924","article-title":"Control of brain tumor growth by reactivating myeloid cells with niacin","volume":"12","author":"Sarkar","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-023-01376-2_bib12","author":"US National Library of Medicine"},{"key":"10.1007\/s13311-023-01376-2_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.667032","article-title":"Niacin enhancement for Parkinson's disease: an effectiveness trial","volume":"13","author":"Chong","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/jnnp.2003.025858","article-title":"Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline","volume":"75","author":"Morris","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD(+) homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/genes12111776","article-title":"NAD(+) metabolism and diseases with motor dysfunction","volume":"12","author":"Lundt","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1007\/s13311-023-01376-2_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110841","article-title":"Kynurenine pathway, NAD(+) synthesis, and mitochondrial function: targeting tryptophan metabolism to promote longevity and healthspan","volume":"132","author":"Castro-Portuguez","year":"2020","journal-title":"Exp Gerontol"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.14336\/AD.2021.0523","article-title":"Pharmacology and potential complications of nicotinamide adenine dinucleotide precursors","volume":"12","author":"She","year":"2021","journal-title":"Aging Dis"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ajcn\/3.3.244","article-title":"Niacin-tryptophan relationships in the development of pellagra","volume":"3","author":"Horwitt","year":"1955","journal-title":"Am J Clin Nutr"},{"issue":"6431","key":"10.1007\/s13311-023-01376-2_bib20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.aau3903","article-title":"Direct stimulation of NADP(+) synthesis through Akt-mediated phosphorylation of NAD kinase","volume":"363","author":"Hoxhaj","year":"2019","journal-title":"Science"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1073\/pnas.1417290112","article-title":"NAD kinase controls animal NADP biosynthesis and is modulated via evolutionarily divergent calmodulin-dependent mechanisms","volume":"112","author":"Love","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/ars.2017.7216","article-title":"NAD(H) and NADP(H) redox couples and cellular energy metabolism","volume":"28","author":"Xiao","year":"2018","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD(+) in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab"},{"issue":"7","key":"10.1007\/s13311-023-01376-2_bib25","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202113943","article-title":"NAD(+) homeostasis in human health and disease","volume":"13","author":"Zapata-P\u00e9rez","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib26","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1007\/s12035-021-02387-w","article-title":"Sirtuin acetylation and deacetylation: a complex paradigm in neurodegenerative disease","volume":"58","author":"Khan","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"6265","key":"10.1007\/s13311-023-01376-2_bib27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"issue":"5\u20136","key":"10.1007\/s13311-023-01376-2_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1101\/gad.335109.119","article-title":"Interplay between compartmentalized NAD(+) synthesis and consumption: a focus on the PARP family","volume":"34","author":"Cohen","year":"2020","journal-title":"Genes Dev"},{"issue":"9","key":"10.1007\/s13311-023-01376-2_bib29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tibs.2021.01.014","article-title":"Rapid detection and signaling of DNA damage by PARP-1","volume":"46","author":"Pandey","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"10.1007\/s13311-023-01376-2_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2020.02.012","article-title":"The SARM1 axon degeneration pathway: Control of the NAD(+) metabolome regulates axon survival in health and disease","volume":"63","author":"Figley","year":"2020","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib31","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"issue":"7","key":"10.1007\/s13311-023-01376-2_bib32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD(+) ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2021.04.003","article-title":"Evolving concepts in NAD(+) metabolism","volume":"33","author":"Chini","year":"2021","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-023-01376-2_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102514","article-title":"The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions","volume":"101","author":"Lee","year":"2022","journal-title":"Cell Calcium"},{"key":"10.1007\/s13311-023-01376-2_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fendo.2020.00365","article-title":"The role of the pentose phosphate pathway in diabetes and cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101116","article-title":"NADPH and glutathione redox link TCA cycle activity to endoplasmic reticulum homeostasis","volume":"23","author":"Gansemer","year":"2020","journal-title":"iScience"},{"key":"10.1007\/s13311-023-01376-2_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7086512","article-title":"Oxidative stress, neuroinflammation, and NADPH axidase: implications in the pathogenesis and treatment of Alzheimer's disease","volume":"2021","author":"Ganguly","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1007\/s13311-023-01376-2_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6631805","article-title":"Pathophysiology and therapeutic potential of NADPH oxidases in ischemic stroke-induced oxidative stress","volume":"2021","author":"Duan","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"14","key":"10.1007\/s13311-023-01376-2_bib39","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/cvr\/cvz303","article-title":"Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+\/nicotinamide","volume":"116","author":"Horimatsu","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2020.04.008","article-title":"Niacin cures systemic NAD(+) deficiency and improves muscle performance in adult-onset mitochondrial myopathy","volume":"31","author":"Pirinen","year":"2020","journal-title":"Cell Metab"},{"issue":"9","key":"10.1007\/s13311-023-01376-2_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092871","article-title":"Potential therapeutic benefit of NAD(+) supplementation for glaucoma and age-related macular degeneration","volume":"12","author":"Cimaglia","year":"2020","journal-title":"Nutrients"},{"issue":"6326","key":"10.1007\/s13311-023-01376-2_bib42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B(3) modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"10.1007\/s13311-023-01376-2_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101988","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biol"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib44","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.18632\/oncotarget.6538","article-title":"Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors","volume":"7","author":"Duarte-Pereira","year":"2016","journal-title":"Oncotarget"},{"issue":"22","key":"10.1007\/s13311-023-01376-2_bib45","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1111\/febs.13050","article-title":"Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells","volume":"281","author":"Zamporlini","year":"2014","journal-title":"FEBS J"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2125.1991.tb03933.x","article-title":"The bioavailability of sustained release nicotinic acid formulations","volume":"32","author":"Neuvonen","year":"1991","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1007\/s13311-023-01376-2_bib47","first-page":"S68","article-title":"Nicotinic acid: an old drug with a promising future","volume":"153","author":"Bodor","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1007\/s13311-023-01376-2_bib48","doi-asserted-by":"crossref","first-page":"R992","DOI":"10.1152\/ajpregu.00513.2015","article-title":"The hypophagic response to heat stress is not mediated by GPR109A or peripheral \u03b2-OH butyrate","volume":"310","author":"Hepler","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.metabol.2015.10.001","article-title":"Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2","volume":"65","author":"Graff","year":"2016","journal-title":"Metabolism"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib50","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","article-title":"Structure and dynamics of GPCR signaling complexes","volume":"25","author":"Hilger","year":"2018","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112345","article-title":"Metabolite sensing GPCRs: Promising therapeutic targets for cancer treatment?","volume":"9","author":"Cos\u00edn-Roger","year":"2020","journal-title":"Cells"},{"key":"10.1007\/s13311-023-01376-2_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnagi.2019.00089","article-title":"Gi\/o-protein coupled receptors in the aging brain","volume":"11","author":"de Oliveira","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10.1007\/s13311-023-01376-2_bib54","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2013.06.008","article-title":"Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential","volume":"25","author":"Gaidarov","year":"2013","journal-title":"Cell Signal"},{"key":"10.1007\/s13311-023-01376-2_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.662739","article-title":"Participation of short-chain fatty acids and their receptors in gut inflammation and colon cancer","volume":"12","author":"Carretta","year":"2021","journal-title":"Front Physiol"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnx046","article-title":"Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure","volume":"364","author":"Cresci","year":"2017","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib57","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1096\/fj.201801033R","article-title":"Ketones and pain: Unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain","volume":"33","author":"Boccella","year":"2019","journal-title":"FASEB J"},{"issue":"16","key":"10.1007\/s13311-023-01376-2_bib58","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2217\/pgs-2019-0092","article-title":"Activation of HCAR2 by niacin: benefits beyond lipid lowering","volume":"20","author":"Tuteja","year":"2019","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib59","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1124\/mol.105.015750","article-title":"Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A\/PUMA-G)","volume":"68","author":"Tunaru","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1007\/s13311-023-01376-2_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655212","article-title":"Hydroxycarboxylic acid receptor 2, a pleiotropically linked receptor for the multiple sclerosis drug, monomethyl fumarate. Possible implications for the inflammatory response","volume":"12","author":"Parodi","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-015-1422-3","article-title":"Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS","volume":"130","author":"Parodi","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib62","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1172\/JCI72151","article-title":"Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE","volume":"124","author":"Chen","year":"2014","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2009.09.001","article-title":"GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors","volume":"30","author":"Ahmed","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-023-01376-2_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","article-title":"Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells","volume":"831","author":"Li","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib65","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1167\/iovs.18-24398","article-title":"Monomethyl fumarate protects the retina from light-induced retinopathy","volume":"60","author":"Jiang","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib66","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.coph.2013.08.006","article-title":"Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host","volume":"13","author":"Ganapathy","year":"2013","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib68","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/ijms20040974","article-title":"Niacin in the central nervous system: an update of biological aspects and clinical applications","volume":"20","author":"Gasperi","year":"2019","journal-title":"IJMS"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0954-6820.1968.tb10508.x","article-title":"Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia","volume":"183","author":"Carlson","year":"1968","journal-title":"Acta Med Scand"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","article-title":"Molecular identification of nicotinic acid receptor","volume":"303","author":"Soga","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-023-01376-2_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u03b2-hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tem.2016.11.007","article-title":"Hydroxy-carboxylic acid receptor actions in metabolism","volume":"28","author":"Offermanns","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib74","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd3777","article-title":"G protein-coupled receptors for energy metabolites as new therapeutic targets","volume":"11","author":"Blad","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"29","key":"10.1007\/s13311-023-01376-2_bib75","doi-asserted-by":"crossref","first-page":"26649","DOI":"10.1074\/jbc.C500213200","article-title":"(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G","volume":"280","author":"Taggart","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-023-01376-2_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2018.03.041","article-title":"Overexpressing human GPR109A leads to pronounced reduction in plasma triglyceride levels in BAC transgenic rats","volume":"272","author":"Masuda","year":"2018","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1007\/s13311-023-01376-2_bib77","article-title":"Ketone body 3-hydroxybutyrate ameliorates atherosclerosis via receptor Gpr109a-mediated calcium influx","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib78","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/ATVBAHA.108.171363","article-title":"Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice","volume":"28","author":"van der Hoorn","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1007\/s13311-023-01376-2_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pharmtox.48.113006.094746","article-title":"Nicotinic acid: pharmacological effects and mechanisms of action","volume":"48","author":"Gille","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib80","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbrc.2007.02.079","article-title":"Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice","volume":"355","author":"Hernandez","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib81","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","article-title":"Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib82","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1096\/fj.12-223933","article-title":"The role of HCA2 (GPR109A) in regulating macrophage function","volume":"27","author":"Zandi-Nejad","year":"2013","journal-title":"FASEB J"},{"key":"10.1007\/s13311-023-01376-2_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4944","article-title":"The \u03b2-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages","volume":"5","author":"Rahman","year":"2014","journal-title":"Nat Commun"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib84","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/d41573-020-00173-2","article-title":"HCAR3: an underexplored metabolite sensor","volume":"19","author":"Kapolka","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s13311-023-01376-2_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fendo.2011.00051","article-title":"Biological roles and therapeutic potential of hydroxy-carboxylic acid receptors","volume":"2","author":"Ahmed","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11 a","key":"10.1007\/s13311-023-01376-2_bib86","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.amjcard.2007.09.080","article-title":"Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?","volume":"100","author":"Kamanna","year":"2007","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib87","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bcp.2005.11.019","article-title":"Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways","volume":"71","author":"Knowles","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-023-01376-2_bib88","doi-asserted-by":"crossref","DOI":"10.1177\/11779322211056122","article-title":"Structural and energetic insights into the interaction of niacin with the GPR109A receptor","volume":"15","author":"Adepu","year":"2021","journal-title":"Bioinform Biol Insights"},{"issue":"7","key":"10.1007\/s13311-023-01376-2_bib89","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41594-021-00616-3","article-title":"Heat-dependent opening of TRPV1 in the presence of capsaicin","volume":"28","author":"Kwon","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.1007\/s13311-023-01376-2_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5806321","article-title":"Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and some visceral systems","volume":"2019","author":"Storozhuk","year":"2019","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib91","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/ATVBAHA.113.303346","article-title":"Nicotinic acid activates the capsaicin receptor TRPV1: potential mechanism for cutaneous flushing","volume":"34","author":"Ma","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib92","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FJC.0000000000000181","article-title":"TRPV1 channels are involved in niacin-induced cutaneous vasodilation in mice","volume":"65","author":"Clifton","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1007\/s13311-023-01376-2_bib93","series-title":"Kynurenine and Serotonin Pathways. 294","first-page":"675","article-title":"Effect of Huntington's and Alzheimer's diseases on the transport of nicotinic acid or nicotinamide across the human blood-brain barrier","author":"Hankes","year":"1991"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib94","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann Neurol"},{"issue":"16","key":"10.1007\/s13311-023-01376-2_bib95","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1073\/pnas.0812500106","article-title":"Extensive remyelination of the CNS leads to functional recovery","volume":"106","author":"Duncan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib96","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: A review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib97","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","article-title":"Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation","volume":"26","author":"Kotter","year":"2006","journal-title":"J Neurosci"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib98","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol Chem"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib99","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1007\/s13311-023-01376-2_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.08.011","article-title":"Acidic extracellular pH promotes accumulation of free cholesterol in human monocyte-derived macrophages via inhibition of ACAT1 activity","volume":"312","author":"Lee-Rueckert","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1007\/s13311-023-01376-2_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12950-019-0211-5","article-title":"Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Ho","year":"2019","journal-title":"J Inflamm (Lond)"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib102","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"16","key":"10.1007\/s13311-023-01376-2_bib103","article-title":"Regulation of brain cholesterol: What role do liver X receptors play in neurodegenerative diseases?","volume":"20","author":"Mouzat","year":"2019","journal-title":"IJMS"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib104","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR regulation of brain cholesterol: from development to disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","article-title":"Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis","volume":"24","author":"Berghoff","year":"2021","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1007\/s13311-023-01376-2_bib107","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","article-title":"Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"ATVB"},{"issue":"16_Supplement","key":"10.1007\/s13311-023-01376-2_bib108","doi-asserted-by":"crossref","first-page":"C43","DOI":"10.1016\/j.jacc.2015.06.1188","article-title":"Effects of niacin on ApoE-\/- mice' adipose tissue, serum lipid and atherosclerosis","volume":"66","author":"Du","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib109","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bcp.2003.09.014","article-title":"Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin","volume":"67","author":"Rubic","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/ATVBAHA.115.306268","article-title":"Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects","volume":"36","author":"Ronsein","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib111","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacl.2013.06.007","article-title":"Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients","volume":"7","author":"Franceschini","year":"2013","journal-title":"J Clin Lipidol"},{"issue":"6376","key":"10.1007\/s13311-023-01376-2_bib112","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","article-title":"Defective cholesterol clearance limits remyelination in the aged central nervous system","volume":"359","author":"Cantuti-Castelvetri","year":"2018","journal-title":"Science"},{"issue":"7293","key":"10.1007\/s13311-023-01376-2_bib113","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1007\/s13311-023-01376-2_bib114","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210227","article-title":"TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination","volume":"218","author":"Gouna","year":"2021","journal-title":"J Exp Med"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib115","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191660","article-title":"Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain","volume":"217","author":"Bogie","year":"2020","journal-title":"J Exp Med"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib116","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/glia.22774","article-title":"Macrophages in spinal cord injury: Phenotypic and functional change from exposure to myelin debris: myelin debris altering macrophage function","volume":"63","author":"Wang","year":"2015","journal-title":"Glia"},{"key":"10.1007\/s13311-023-01376-2_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.639757","article-title":"Disrupted lipid metabolism in multiple sclerosis: a role for liver X receptors?","volume":"12","author":"Pineda-Torra","year":"2021","journal-title":"Front Endocrinol"},{"issue":"24","key":"10.1007\/s13311-023-01376-2_bib118","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1073\/pnas.1424951112","article-title":"Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum","volume":"112","author":"Meffre","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib119","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1194\/jlr.M072751","article-title":"Serum lipid profile changes predict neurodegeneration in interferon-\u03b21a-treated multiple sclerosis patients","volume":"58","author":"Uher","year":"2017","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40478-018-0628-8","article-title":"The physiology of foamy phagocytes in multiple sclerosis","volume":"6","author":"Grajchen","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib121","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41582-022-00675-0","article-title":"Emerging therapies to target CNS pathophysiology in multiple sclerosis","volume":"18","author":"Oh","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib122","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nbd.2008.07.011","article-title":"Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice","volume":"32","author":"Zhang","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib123","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3177\/jnsv.28.491","article-title":"Effect of nicotinic acid on myelin lipids in brain of developing rat","volume":"28","author":"Nakashima","year":"1982","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"10291","key":"10.1007\/s13311-023-01376-2_bib125","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson's disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"issue":"9","key":"10.1007\/s13311-023-01376-2_bib127","article-title":"The contribution of microglia to neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"IJMS"},{"issue":"22","key":"10.1007\/s13311-023-01376-2_bib128","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson's disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"IJMS"},{"issue":"7","key":"10.1007\/s13311-023-01376-2_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1007\/s13311-023-01376-2_bib130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2018.05.002","article-title":"Niacin modulates macrophage polarization in Parkinson's disease","volume":"320","author":"Wakade","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-023-01376-2_bib131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2018.08.032","article-title":"Reduced nicotinamide adenine dinucleotide phosphate inhibits MPTP-induced neuroinflammation and neurotoxicity","volume":"391","author":"Zhou","year":"2018","journal-title":"Neuroscience"},{"issue":"5","key":"10.1007\/s13311-023-01376-2_bib132","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10534-018-0131-5","article-title":"Prevention of progression in Parkinson's disease","volume":"31","author":"Aaseth","year":"2018","journal-title":"Biometals"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib133","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0925-4439(97)00016-1","article-title":"NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells","volume":"1361","author":"Vrecko","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1007\/s13311-023-01376-2_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101284","article-title":"The role of vitamins in neurodegenerative disease: an update","volume":"9","author":"Rai","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00702-018-1903-3","article-title":"Human tyrosine hydroxylase in Parkinson's disease and in related disorders","volume":"126","author":"Nagatsu","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib136","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<95::AID-SYN2>3.0.CO;2-U","article-title":"Effects of NADH on dopamine release in rat striatum","volume":"36","author":"Pearl","year":"2000","journal-title":"Synapse"},{"key":"10.1007\/s13311-023-01376-2_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson\u2019s disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib138","article-title":"Lymphoproliferation impairment and oxidative stress in blood cells from early Parkinson\u2019s disease patients","volume":"20","author":"Vida","year":"2019","journal-title":"IJMS"},{"issue":"7886","key":"10.1007\/s13311-023-01376-2_bib139","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib140","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.47.3.644","article-title":"Diet and Parkinson's disease. II: a possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study","volume":"47","author":"Hellenbrand","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib141","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","article-title":"Nutritional and occupational factors influencing the risk of Parkinson\u2019s disease: a case-control study in southeastern Sweden","volume":"14","author":"Fall","year":"1999","journal-title":"Mov Disord"},{"issue":"5\u20136","key":"10.1007\/s13311-023-01376-2_bib142","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10284150500484638","article-title":"Niacin improved rigidity and bradykinesia in a Parkinson\u2019s disease patient but also caused unacceptable nightmares and skin rash\u2013a case report","volume":"8","author":"Alisky","year":"2005","journal-title":"Nutr Neurosci"},{"issue":"12","key":"10.1007\/s13311-023-01376-2_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121881","article-title":"LowdDose niacin supplementation improves motor function in US veterans with Parkinson's disease: A single-center, randomized, placebo-controlled trial","volume":"9","author":"Wakade","year":"2021","journal-title":"Biomedicines"},{"key":"10.1007\/s13311-023-01376-2_bib144","doi-asserted-by":"crossref","DOI":"10.1161\/str.49.suppl_1.WP156","article-title":"Abstract WP156: A phase IIa double-blind, placebo controlled study of extended-release niacin for stroke recovery","volume":"49","author":"Russman","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib145","doi-asserted-by":"crossref","first-page":"021","DOI":"10.23937\/2469-5858\/1510021","article-title":"Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer's disease","volume":"3","author":"Phelan","year":"2017","journal-title":"Gerontol Geriatr Med"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib146","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib147","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/neup.12626","article-title":"Aging and Alzheimer's disease pathology","volume":"40","author":"Sengoku","year":"2020","journal-title":"Neuropathology"},{"issue":"16","key":"10.1007\/s13311-023-01376-2_bib148","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"10.1007\/s13311-023-01376-2_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer's disease and its treatment by different approaches: A review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1007\/s13311-023-01376-2_bib150","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","author":"Yin","year":"2022","journal-title":"FEBS J"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib151","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"issue":"33","key":"10.1007\/s13311-023-01376-2_bib152","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102191118","article-title":"Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-023-01376-2_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937056","article-title":"Cholesterol as a key player in amyloid \u03b2-mediated toxicity in Alzheimer's disease","author":"Rudajev","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"10.1007\/s13311-023-01376-2_bib154","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1194\/jlr.P091033","article-title":"ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease","volume":"60","author":"Marchi","year":"2019","journal-title":"J Lipid Res"},{"issue":"19","key":"10.1007\/s13311-023-01376-2_bib155","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-1148","article-title":"Nicotinic acid supplementation contributes to the amelioration of Alzheimer's disease in mouse models","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib156","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3945\/ajcn.117.157834","article-title":"Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"106","author":"Qin","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1007\/s13311-023-01376-2_bib157","unstructured":"Tamimi AF, Juweid M. Epidemiology and outcome of glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma. Brisbane (AU) 2017."},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib158","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib159","article-title":"Molecular mechanisms of treatment resistance in glioblastoma","volume":"22","author":"Ou","year":"2020","journal-title":"IJMS"},{"key":"10.1007\/s13311-023-01376-2_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"issue":"10","key":"10.1007\/s13311-023-01376-2_bib161","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/jnnp-2020-325334","article-title":"Advances in the management of glioblastoma","volume":"92","author":"Ma","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"19","key":"10.1007\/s13311-023-01376-2_bib162","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","article-title":"Stem cell programs in cancer initiation, progression, and therapy resistance","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"issue":"7015","key":"10.1007\/s13311-023-01376-2_bib163","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"issue":"6","key":"10.1007\/s13311-023-01376-2_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060862","article-title":"Cancer stem cells and radioresistance: DNA repair and beyond","volume":"11","author":"Schulz","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13287-021-02231-x","article-title":"Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives","volume":"12","author":"Alves","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010018","article-title":"Myeloid cells in glioblastoma microenvironment","volume":"10","author":"De Leo","year":"2020","journal-title":"Cells"},{"key":"10.1007\/s13311-023-01376-2_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585616","article-title":"Glioblastoma immune landscape and the potential of new immunotherapies","volume":"11","author":"Daubon","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1007\/s13311-023-01376-2_bib168","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-023-01376-2_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.839526","article-title":"A gut feeling in amyotrophic lateral sclerosis: microbiome of mice and men","volume":"12","author":"Martin","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1007\/s13311-023-01376-2_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1007\/s13311-023-01376-2_bib171","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12356","article-title":"Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model","volume":"3","author":"Wu","year":"2015","journal-title":"Physiol Rep"},{"issue":"2","key":"10.1007\/s13311-023-01376-2_bib172","article-title":"Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice","volume":"13","author":"Figueroa-Romero","year":"2019","journal-title":"Dis Model Mech"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib173","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12916-020-01607-9","article-title":"A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis","volume":"18","author":"Di Gioia","year":"2020","journal-title":"BMC Med"},{"issue":"11","key":"10.1007\/s13311-023-01376-2_bib174","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/ene.13986","article-title":"Antibiotics use and risk of amyotrophic lateral sclerosis in Sweden","volume":"26","author":"Sun","year":"2019","journal-title":"Eur J Neurol"},{"issue":"7770","key":"10.1007\/s13311-023-01376-2_bib175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","article-title":"Potential roles of gut microbiome and metabolites in modulating ALS in mice","volume":"572","author":"Blacher","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1007\/s13311-023-01376-2_bib176","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/dc17-1967","article-title":"Targeted microbiome intervention by microencapsulated delayed-release niacin beneficially affects insulin sensitivity in humans","volume":"41","author":"Fangmann","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1007\/s13311-023-01376-2_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","article-title":"Gut Bacteroides species in health and disease","volume":"13","author":"Zafar","year":"2021","journal-title":"Gut Microbes"},{"issue":"7408","key":"10.1007\/s13311-023-01376-2_bib178","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01376-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923019104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:14:34Z","timestamp":1761808474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923019104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":178,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1878747923019104"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01376-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Promise of Niacin in Neurology","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01376-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}